As more people receive genetic testing after a cancer diagnosis, newer variants have been identified that increase the risk ...

Quest Diagnostics Inc.’s DGX investments in Advanced Diagnostics are paying off, aiming to deliver and scale innovative services that improve patient care and drive growth. The company focuses on ...

Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have earned a consensus rating of “Hold” from the fifteen ...

As more people receive genetic testing after a cancer diagnosis, newer variants have been identified that increase risk of ...

Quantbot Technologies LP grew its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 236.6% during ...

Science is discovery and discovery evolve. Few discoveries have elicited as much excitement in the scientific world in recent times ...

CRISPR technology has revolutionised genetic engineering, offering unprecedented precision in DNA editing with vast implications for medicine, agriculture and conservation. Yet, its power demands ...

OvaSuite revenue of $9.2 million and volume of 24,305 units sold AUSTIN, TX / ACCESS Newswire / March 27, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") , a bio-analytical based women's ...

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

Real world data show that immunotherapy leads to better overall survival outcomes than chemotherapy in patients with ...